Drug:
Reaction: BLOOD PRESSURE INCREASED
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940689 |
CN |
56 | 2 |
Pyrexia, Chills, Tachypnoea, Blood pressure increased, Palpitations, Blood pressure decreased, Cardiac disorder, |
||||
GLOFITAMAB, PROMETHAZINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 2 | 26940725 |
US |
1 | |
Agitation, Blood pressure increased, Pain, |
||||
ABALOPARATIDE, ALPRAZOLAM, LATANOPROST, LORATADINE, LORATADINE ORAL, ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, LOSARTAN, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 3 | 26940763 |
US |
2 | |
Hernia repair, Scar, Fear of injection, Allergy to chemicals, Otorrhoea, Visual impairment, Nasal congestion, Sinusitis, Hernia, Dyspepsia, Eczema, Dyspnoea, Dizziness, Blood pressure increased, Nausea, Palpitations, Blood calcium increased, Headache, Arthralgia, Incorrect dose administered, Product distribution issue, Intentional dose omission, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, CALCIUM, |
||||
| 4 | 26940886 |
EU |
79 | 2 |
Local anaesthetic systemic toxicity, Bilateral tonic clonic seizure, Unresponsive to stimuli, Hyperpyrexia, Acute myocardial infarction, Cytotoxic oedema, Gaze palsy, Mental status changes, Mydriasis, Paraesthesia, Dyskinesia, Blood pressure increased, Supraventricular tachycardia, Cognitive disorder, Spinal osteoarthritis, Neutrophilia, Lumbar spinal stenosis, Accidental exposure to product, Product use in unapproved indication, |
||||
LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, |
||||
| 5 | 26940955 |
EU |
79 | 2 |
Bilateral tonic clonic seizure, Accidental exposure to product, Troponin I increased, Paraesthesia, Cognitive disorder, Lumbar spinal stenosis, Spinal osteoarthritis, Electroencephalogram abnormal, Neutrophilia, Supraventricular tachycardia, Blood pressure increased, Dyskinesia, Mydriasis, Urinary incontinence, Mental status changes, Acute myocardial infarction, Cytotoxic oedema, Hyperpyrexia, Unresponsive to stimuli, Local anaesthetic systemic toxicity, |
||||
LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 6 | 26940990 |
US |
2 | |
Taste disorder, Weight decreased, Decreased appetite, Blood pressure increased, Nausea, Headache, Rash, Dizziness, Alopecia, Dry skin, |
||||
ABALOPARATIDE, |
||||
| 7 | 26941032 |
US |
75 | 2 |
Alopecia, Gastrointestinal disorder, Gout, Blood thyroid stimulating hormone increased, Abdominal distension, Blood pressure increased, Bone pain, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 8 | 26941099 |
US |
2 | |
Vitamin D deficiency, Blood pressure fluctuation, Feeling abnormal, Tachycardia, Blood pressure increased, Heart rate increased, Palpitations, Injection site pain, Injection site bruising, Headache, Accidental overdose, Product dose omission issue, Circumstance or information capable of leading to medication error, |
||||
ABALOPARATIDE, |
||||
| 9 | 26941174 |
US |
2 | |
Spinal pain, Paraesthesia, Cardiovascular symptom, Grip strength decreased, Injection site urticaria, Purpura, Blood pressure increased, Heart rate increased, Dizziness, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 10 | 26941223 |
EU |
79 | 2 |
Bilateral tonic clonic seizure, Mental status changes, Anuria, Unresponsive to stimuli, Gaze palsy, Mydriasis, Chorea, Hyperpyrexia, Blood pressure increased, Supraventricular tachycardia, Acute myocardial infarction, Local anaesthetic systemic toxicity, Troponin I increased, Neutrophilia, Accidental exposure to product, Paraesthesia, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 11 | 26941361 |
EU |
47 | 2 |
Blood pressure increased, Unresponsive to stimuli, Fatigue, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 12 | 26941363 |
JP |
5 | 1 |
Blood pressure increased, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 13 | 26941381 |
US |
81 | 1 |
Blood pressure increased, Nausea, |
||||
DEUTETRABENAZINE, |
||||
| 14 | 26941460 |
US |
65 | 2 |
Seronegative arthritis, Transient ischaemic attack, Body mass index increased, Blood pressure increased, Carpal tunnel syndrome, Contusion, Neck pain, Cubital tunnel syndrome, Left ventricular dysfunction, Osteoarthritis, Fibromyalgia, Hypocalcaemia, Spinal osteoarthritis, Hypertonia, Arthralgia, Fall, Postmenopause, Somatic dysfunction, Meniscus injury, Vitamin B12 deficiency, Vitamin D deficiency, Pain, Brain fog, Joint swelling, |
||||
ETANERCEPT, DULOXETINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERGOCALCIFEROL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, COLCHICINE, |
||||
| 15 | 26941524 |
KH |
2 | |
Cholelithiasis, Chronic myeloid leukaemia, Malignant neoplasm progression, Vaginal haemorrhage, Uterine haemorrhage, Haematochezia, Hypothyroidism, Malaise, Diabetes mellitus, Loose tooth, Blood creatinine decreased, Varicose vein, Drug intolerance, Cardiac disorder, Crying, Transferrin saturation decreased, Blood cholesterol increased, Microalbuminuria, White blood cell count increased, Prothrombin time shortened, Blood lactate dehydrogenase abnormal, Lymphocyte count abnormal, Antinuclear antibody positive, Blood triglycerides increased, Product dose omission issue, Iron deficiency anaemia, Alanine aminotransferase abnormal, Aspartate aminotransferase abnormal, Manganese increased, Neutrophil count increased, Mean cell haemoglobin concentration abnormal, Neck pain, Back pain, Pallor, Ocular hyperaemia, Pain, Peripheral swelling, Oedema peripheral, Normochromic normocytic anaemia, Hepatomegaly, Dyslipidaemia, Hyperglycaemia, Hepatic steatosis, Arthralgia, Pain in extremity, Chest pain, Haemoglobin decreased, Anaemia, Dyspnoea, Anxiety, Tachycardia, White blood cell count abnormal, Cough, Blood pressure increased, Blood iron decreased, Cytogenetic analysis abnormal, Hypertension, Depression, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NILOTINIB, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, CALCIUM, |
||||
| 16 | 26941528 |
CO |
73 | 2 |
Osteoporosis postmenopausal, Neck pain, Blood pressure increased, Headache, Arthralgia, Blood calcium decreased, Nausea, Illness, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 17 | 26941756 |
US |
66 | 2 |
Coccydynia, Presyncope, Blood pressure increased, Heart rate increased, Back pain, Pain, |
||||
ABALOPARATIDE, ATENOLOL, BIMEKIZUMAB, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 18 | 26941892 |
US |
66 | 2 |
Blood pressure increased, Blood calcium increased, Palpitations, Headache, Malaise, Pain of skin, Bursitis, Flushing, Bone pain, Pain, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, HYDROCORTISONE, CALCIUM, |
||||
| 19 | 26942037 |
US |
2 | |
Sleep disorder, Blood pressure increased, |
||||
ABALOPARATIDE, ACETAMINOPHEN, RASAGILINE MESYLATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 20 | 26943878 |
CA |
70 | 2 |
Blood pressure increased, Blood pressure systolic abnormal, Blood pressure systolic increased, Body temperature decreased, Erythema, Nausea, Oxygen saturation decreased, Pain in extremity, Peripheral swelling, Rheumatoid arthritis, Tenderness, Intercepted medication error, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CALCIUM, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 21 | 26943933 |
CA |
60 | 1 |
Blood pressure increased, Prostatic operation, Nausea, Vomiting, Fatigue, Suspected off label use, Suspected off label use, Intentional product misuse, |
||||
DIMENHYDRINATE, DIMENHYDRINATE, DIMENHYDRINATE, |
||||
| 22 | 26944034 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Epilepsy, Anxiety, Ankle fracture, Migraine, Hypertension, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Diarrhoea, Nausea, Vomiting, Blood alkaline phosphatase increased, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, Foot fracture, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Dizziness, White blood cell count decreased, Haematocrit decreased, Haemoglobin decreased, Depression, Skin discolouration, Malaise, Emotional distress, Headache, Abnormal behaviour, Ligament sprain, Myopia, Colitis, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Petit mal epilepsy, Choking, Asphyxia, Sarcoma, Metastases to lung, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Electric shock sensation, Full blood count decreased, Fat tissue increased, Fluid retention, Pain, Dry eye, Back pain, Fatigue, Dysgeusia, Abdominal discomfort, Diarrhoea, Headache, Depressed mood, Memory impairment, Weight decreased, Blood sodium increased, Aversion, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Gastrointestinal disorder, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Red cell distribution width increased, Elliptocytosis, Atrioventricular block first degree, Discomfort, Mean cell volume increased, Blood glucose increased, Rouleaux formation, Red blood cell sedimentation rate increased, Limb deformity, Oral herpes, Ill-defined disorder, Arthritis, Hypersensitivity, Pruritus, Pyrexia, Dry skin, Lymphocyte count decreased, Red blood cell count decreased, Decreased immune responsiveness, Thyroid mass, Visual impairment, Neoplasm, Gingival disorder, Pain in extremity, Vision blurred, Chills, Herpes virus infection, Agitation, Confusional state, Catheter site pain, Gastrooesophageal reflux disease, Oesophagitis, Stress, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Viral diarrhoea, Nasopharyngitis, Alopecia, Tension headache, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, CALCIUM, MORPHINE, |
||||
| 23 | 26944324 |
US |
2 | |
Blood pressure increased, Flushing, Erythema, Product substitution issue, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 24 | 26944392 |
EU |
79 | 2 |
Local anaesthetic systemic toxicity, Bilateral tonic clonic seizure, Unresponsive to stimuli, Hyperpyrexia, Acute myocardial infarction, Cytotoxic oedema, Gaze palsy, Mental status changes, Mydriasis, Paraesthesia, Dyskinesia, Blood pressure increased, Supraventricular tachycardia, Cognitive disorder, Spinal osteoarthritis, Neutrophilia, Lumbar spinal stenosis, Incorrect route of product administration, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 25 | 26944420 |
53 | 2 | |
Blood pressure increased, Urticaria, Incorrect drug administration rate, |
||||
LUBIPROSTONE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUPROPION, CALCIUM, CYCLOSPORINE, HYDROCHLOROTHIAZIDE, HYDROXYZINE, LEVOCARNITINE, LEVOCARNITINE ORAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LOSARTAN POTASSIUM, LOSARTAN, CYCLOSPORINE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 26 | 26944819 |
US |
2 | |
Oxygen saturation decreased, Blood test abnormal, Blood pressure increased, |
||||
ABALOPARATIDE, METHOTREXATE, METHOTREXATE SODIUM, UPADACITINIB, HYDROXYCHLOROQUINE, |
||||
| 27 | 26944824 |
US |
2 | |
Blood urine present, Gastrooesophageal reflux disease, Balance disorder, Polyuria, Musculoskeletal discomfort, Blood pressure increased, Injection site pain, Injection site erythema, Injection site swelling, Injection site reaction, Nausea, Fatigue, Vertigo, Asthenia, Renal disorder, Blood glucose increased, Product dose omission issue, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, VALSARTAN, VALSARTAN ORAL, HYOSCYAMINE SULFATE, MAGNESIUM, FLUTICASONE PROPIONATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TAMSULOSIN HYDROCHLORIDE, PEPPERMINT OIL, |
||||
| 28 | 26944872 |
US |
60 | 2 |
Tremor, Chills, Blood pressure increased, Heart rate increased, Back pain, |
||||
ABALOPARATIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 29 | 26944962 |
US |
2 | |
Weight decreased, Blood pressure increased, Palpitations, Headache, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 30 | 26945021 |
US |
2 | |
Chest discomfort, Blood pressure fluctuation, General physical health deterioration, Sinusitis bacterial, Chronic sinusitis, Feeling abnormal, Blood pressure increased, Heart rate increased, Headache, Palpitations, Nausea, Product use complaint, Device issue, |
||||
ABALOPARATIDE, |
||||
| 31 | 26945080 |
US |
2 | |
Arthritis, Blood pressure increased, Injection site bruising, Headache, |
||||
ABALOPARATIDE, CARVEDILOL, IRON, PANTOPRAZOLE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 32 | 26945100 |
US |
2 | |
Hospitalisation, Joint stiffness, Condition aggravated, Tendon pain, Urine abnormality, Blood pressure increased, |
||||
ABALOPARATIDE, |
||||
| 33 | 26945115 |
US |
2 | |
Pain in jaw, Blood pressure decreased, Tinnitus, Blood pressure increased, Dizziness, Injection site erythema, Injection site pruritus, Injection site rash, Headache, Insomnia, Therapeutic response unexpected, Off label use, Incorrect dose administered, |
||||
ABALOPARATIDE, |
||||
| 34 | 26945190 |
US |
65 | 2 |
Middle insomnia, Blood pressure increased, Headache, Pain in extremity, Arthralgia, Bone pain, Pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, EVOLOCUMAB, ALBUTEROL SULFATE, FISH OIL, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SPIRONOLACTONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, |
||||
| 35 | 26945215 |
US |
77 | 2 |
Visual impairment, Chest pain, Stress, Nausea, Headache, Dyspnoea, Blood pressure increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, NEBIVOLOL HYDROCHLORIDE, |
||||
| 36 | 26945242 |
US |
2 | |
Myalgia, Dry skin, Urinary tract infection, Blood pressure increased, Dyspnoea, Vomiting, Palpitations, Bone pain, Nausea, Heart rate increased, Abdominal distension, Insomnia, Pruritus, Fatigue, Arthralgia, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METHOCARBAMOL, FEXOFENADINE HYDROCHLORIDE, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM CARBONATE, ERGOCALCIFEROL, CARVEDILOL, FISH OIL, CARVEDILOL, CARBOXYMETHYLCELLULOSE SODIUM, METHIMAZOLE, FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CALCIUM CARBONATE, ANTACID, PYRITHIONE ZINC, CETIRIZINE HYDROCHLORIDE, |
||||
| 37 | 26945341 |
US |
2 | |
Blood pressure increased, Palpitations, |
||||
ABALOPARATIDE, |
||||
| 38 | 26945364 |
CN |
72 | 2 |
Myocardial necrosis marker increased, Myocarditis, Blood pressure increased, |
||||
FRUQUINTINIB, |
||||
| 39 | 26945385 |
US |
82 | 2 |
Skin discolouration, Blood pressure increased, Dizziness, Headache, Malaise, |
||||
ABALOPARATIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, ADRENALINUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LATANOPROST, MAGNESIUM, METHOCARBAMOL, METHOCARBAMOL TABLETS, TRIAMCINOLONE ACETONIDE, |
||||
| 40 | 26945449 |
US |
70 | 2 |
Blood pressure increased, Heart rate increased, |
||||
ABALOPARATIDE, |
||||
| 41 | 26945489 |
80 | 2 | |
Tachypnoea, Temperature intolerance, Chest pain, Throat irritation, Blood pressure increased, Respiratory rate decreased, Heart rate increased, |
||||
IOPROMIDE, IOPROMIDE, |
||||
| 42 | 26945495 |
US |
2 | |
Blood pressure increased, Dizziness, Heart rate increased, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 43 | 26945648 |
US |
29 | 2 |
Rhinorrhoea, Upper-airway cough syndrome, Cough, Influenza, Pain, Abdominal tenderness, Migraine, Dehydration, Nausea, Blood pressure increased, Heart rate increased, Oropharyngeal pain, Hypoaesthesia, Vomiting, Drug ineffective, |
||||
OMALIZUMAB, OSELTAMIVIR PHOSPHATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, FAMOTIDINE, FLUOXETINE HYDROCHLORIDE, HYDROCORTISONE ACETATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, NORGESTREL AND ETHINYL ESTRADIOL, METHYLPHENIDATE HYDROCHLORIDE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, MELOXICAM, |
||||
| 44 | 26945786 |
US |
2 | |
Neck pain, Blood pressure increased, Headache, Palpitations, Nausea, Insomnia, Back pain, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 45 | 26945870 |
US |
2 | |
Tension headache, Blood pressure increased, Product dose omission issue, |
||||
| 46 | 26945950 |
US |
58 | 2 |
Blood pressure increased, Neck pain, Injection site pain, Heart rate increased, Dizziness, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 47 | 26946055 |
US |
2 | |
Flatulence, Blood pressure increased, Dizziness, Palpitations, Abdominal distension, Injection site pain, Injection site bruising, Headache, Muscle spasms, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 48 | 26946094 |
US |
79 | 2 |
Bronchitis, Pain, Blood pressure increased, Peripheral swelling, Blood pressure decreased, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 49 | 26946179 |
US |
1 | |
Blood pressure increased, Initial insomnia, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 50 | 26946301 |
US |
57 | 2 |
Blood pressure increased, Headache, Dizziness, Heart rate increased, Needle issue, Device physical property issue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 51 | 26946306 |
US |
2 | |
Blood pressure fluctuation, Blood pressure increased, Nausea, Dizziness, Headache, Heart rate increased, Diarrhoea, |
||||
ABALOPARATIDE, |
||||
| 52 | 26946348 |
US |
72 | 1 |
Balance disorder, Blood pressure increased, |
||||
ABALOPARATIDE, |
||||
| 53 | 26946352 |
US |
70 | 2 |
Burning sensation, Blood pressure increased, Rash, Pruritus, Muscle spasms, Injection site swelling, |
||||
ABALOPARATIDE, |
||||
| 54 | 26946443 |
US |
2 | |
Adverse event, Blood pressure increased, Palpitations, |
||||
ABALOPARATIDE, |
||||
| 55 | 26946448 |
US |
76 | 2 |
Dry mouth, Condition aggravated, Respiratory rate increased, Blood pressure increased, Abdominal discomfort, Pain, Arthralgia, Heart rate increased, Product administered at inappropriate site, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 56 | 26946506 |
US |
79 | 2 |
Blood pressure increased, Atrial fibrillation, Feeling abnormal, Chest discomfort, Contraindicated product administered, |
||||
METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MAGNESIUM, LISINOPRIL, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, UMECLIDINIUM, FUROSEMIDE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FAMOTIDINE, LORATADINE, LORATADINE TABLET, PREDNISONE, DICLOFENAC SODIUM, LEFLUNOMIDE, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, METOPROLOL SUCCINATE, |
||||
| 57 | 26946691 |
US |
51 | 2 |
Head discomfort, Ocular discomfort, Dysarthria, Dry mouth, Pollakiuria, Dyspnoea, Blood pressure increased, Dizziness, Headache, Asthenia, Heart rate increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, FLUTICASONE PROPIONATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, IPRATROPIUM BROMIDE AND ALBUTEROL, PREDNISONE, CYCLOSPORINE, CARBOXYMETHYLCELLULOSE SODIUM, GABAPENTIN, LIFITEGRAST, MYCOPHENOLIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, FENOFIBRATE, VALACYCLOVIR HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ALBUTEROL SULFATE, |
||||
| 58 | 26946802 |
US |
2 | |
Blood pressure increased, Bone pain, Product dose omission issue, Product use in unapproved indication, |
||||
ABALOPARATIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, HYDROXYCHLOROQUINE, LACOSAMIDE, LEFLUNOMIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LISINOPRIL, PANTOPRAZOLE, PREDNISOLONE ACETATE, ETANERCEPT, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 59 | 26946854 |
US |
63 | 2 |
Blood pressure increased, |
||||
ABALOPARATIDE, |
||||
| 60 | 26946934 |
US |
79 | 2 |
Fall, Blood pressure increased, |
||||
ABALOPARATIDE, |
||||
| 61 | 26946942 |
US |
1 | |
Anxiety, Blood sodium decreased, Blood pressure increased, Palpitations, Heart rate increased, Headache, Insomnia, |
||||
ABALOPARATIDE, |
||||
| 62 | 26946958 |
US |
2 | |
Hypotension, Influenza like illness, Blood pressure increased, Nausea, Dizziness, |
||||
ABALOPARATIDE, |
||||
| 63 | 26946969 |
US |
79 | 2 |
Blood pressure increased, Joint injury, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 64 | 26947032 |
US |
64 | 2 |
Blood pressure increased, Headache, Injection site pain, |
||||
ABALOPARATIDE, GABAPENTIN, VALSARTAN, VALSARTAN ORAL, |
||||
| 65 | 26947036 |
US |
2 | |
Blood pressure decreased, Blood pressure increased, Dizziness, Injection site reaction, Injection site bruising, |
||||
ABALOPARATIDE, LISINOPRIL, |
||||
| 66 | 26947181 |
US |
2 | |
Blood pressure increased, Dizziness, |
||||
ABALOPARATIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FUROSEMIDE, ERGOCALCIFEROL, |
||||
| 67 | 26947316 |
US |
70 | 2 |
Blood pressure increased, Dizziness, Headache, Fatigue, Influenza, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 68 | 26947455 |
US |
2 | |
Blood pressure increased, |
||||
ABALOPARATIDE, |
||||
| 69 | 26947457 |
US |
2 | |
Weight decreased, Blood pressure increased, |
||||
ABALOPARATIDE, |
||||
| 70 | 26947666 |
US |
2 | |
Syncope, Nervousness, Head discomfort, Hyperhidrosis, Blood pressure increased, Headache, Dizziness, Malaise, |
||||
ABALOPARATIDE, ABALOPARATIDE, ROSUVASTATIN CALCIUM, PAROXETINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, |
||||
| 71 | 26947721 |
US |
63 | 2 |
Supraventricular extrasystoles, Stress, Blood pressure increased, Headache, Dizziness, |
||||
ABALOPARATIDE, EVOLOCUMAB, DUPILUMAB, |
||||
| 72 | 26947729 |
US |
2 | |
Anxiety, Blood pressure increased, Palpitations, Incorrect dose administered, |
||||
ABALOPARATIDE, |
||||
| 73 | 26947762 |
US |
2 | |
Blood pressure increased, Heart rate increased, |
||||
ABALOPARATIDE, |
||||
| 74 | 26947792 |
US |
2 | |
Chills, Hyperhidrosis, Blood pressure increased, Headache, Vomiting, |
||||
ABALOPARATIDE, |
||||
| 75 | 26947819 |
US |
2 | |
Blood cholesterol increased, Blood pressure increased, |
||||
ABALOPARATIDE, |
||||
| 76 | 26947972 |
US |
2 | |
Emotional distress, Flushing, Glossitis, Blood pressure increased, Decreased appetite, Fatigue, Bone pain, Constipation, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 77 | 26948004 |
US |
74 | 2 |
Feeling cold, Brain fog, Tremor, Dizziness postural, Anxiety, Blood pressure fluctuation, Weight decreased, Blood pressure decreased, Abdominal discomfort, Decreased appetite, Feeling abnormal, Blood pressure increased, Dizziness, Heart rate increased, Constipation, Headache, Vertigo, Fatigue, Nausea, Therapy interrupted, Intentional dose omission, |
||||
ABALOPARATIDE, ABALOPARATIDE, ICOSAPENT ETHYL, ICOSAPENT ETHYL CAPSULES, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, EVOLOCUMAB, |
||||
| 78 | 26948011 |
US |
2 | |
Blood pressure increased, Back pain, Fatigue, Palpitations, |
||||
ABALOPARATIDE, |
||||
| 79 | 26948028 |
JP |
77 | 1 |
Blood pressure increased, |
||||
ZANUBRUTINIB, ACYCLOVIR, TOLVAPTAN, ALLOPURINOL, BISOPROLOL FUMARATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, SPIRONOLACTONE, AMLODIPINE, SACUBITRIL AND VALSARTAN, MONTELUKAST, VIBEGRON, RISEDRONATE SODIUM, |
||||
| 80 | 26948142 |
US |
2 | |
Sleep disorder, Blood pressure increased, Nausea, Heart rate increased, |
||||
ABALOPARATIDE, |
||||
| 81 | 26948193 |
US |
2 | |
Heart rate irregular, Blood pressure increased, Headache, |
||||
ABALOPARATIDE, |
||||
| 82 | 26948201 |
US |
72 | 2 |
Exercise tolerance decreased, Blood pressure increased, Influenza, Myalgia, Hepatic enzyme increased, Nervousness, Anxiety, Blood creatinine increased, Arthralgia, Pain, Fatigue, Heart rate increased, Product dose omission issue, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 83 | 26951368 |
51 | 2 | |
Infusion related reaction, Urticaria, Blood pressure increased, Vomiting, |
||||
ACETAMINOPHEN 500MG, ACETAMINOPHEN, ACETAMINOPHEN 325MG, ACETAMINOPHEN 650MG, |
||||
| 84 | 26951651 |
48 | 2 | |
Myocardial infarction, Blood pressure increased, |
||||
| 85 | 26934094 |
CA |
69 | 1 |
Arthritis, Hypoaesthesia, Oxygen saturation decreased, Product use issue, Thermal burn, Weight decreased, Body temperature decreased, Insomnia, Weight increased, Dry eye, Micturition disorder, Oedema peripheral, Ligament rupture, Blood pressure increased, Nerve compression, Gingival ulceration, Musculoskeletal stiffness, Blood pressure fluctuation, Pain in extremity, Joint range of motion decreased, Arthralgia, Blood pressure decreased, Mass, Infusion related reaction, Rash, Skin abrasion, Peripheral swelling, Pain, Dysuria, Paraesthesia, Skin papilloma, Blood pressure diastolic decreased, Dry skin, Neck pain, Skin discolouration, Blood pressure systolic increased, Cystitis bacterial, Blood pressure diastolic abnormal, Inflammation, Mouth ulceration, Fall, Anaemia, Rib fracture, Drug ineffective, Musculoskeletal stiffness, Back pain, Ill-defined disorder, Blood pressure systolic abnormal, Heart rate decreased, Pruritus, Osteoarthritis, Dry throat, Arthralgia, Arthralgia, Arthralgia, Pain, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CELECOXIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FOLIC ACID, |
||||
| 86 | 26934144 |
78 | ||
Blood pressure increased, |
||||
METOPROLOL TARTRATE, OLMESARTAN MEDOXOMIL, |
||||
| 87 | 26934146 |
78 | ||
Blood pressure increased, |
||||
METOPROLOL TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 88 | 26934150 |
|||
Blood pressure increased, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 89 | 26934179 |
71 | ||
Temporomandibular pain and dysfunction syndrome, Blood pressure increased, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, CALCIUM, ADALIMUMAB, PREDNISONE, ALISKIREN HEMIFUMARATE, ERGOCALCIFEROL, |
||||
| 90 | 26934284 |
US |
70 | |
Atrial fibrillation, Blood pressure increased, Rash erythematous, Application site exfoliation, Application site irritation, Application site pain, |
||||
AMMONIUM LACTATE, |
||||
| 91 | 26934340 |
39 | ||
Blood pressure increased, Drug ineffective, Product complaint, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ALLOPURINOL, |
||||
| 92 | 26934451 |
84 | 1 | |
Urinary tract infection, Bradycardia, Blood pressure increased, Confusional state, |
||||
| 93 | 26934494 |
|||
Blood pressure increased, |
||||
| 94 | 26934501 |
69 | ||
Blood pressure increased, Drug ineffective, Product complaint, |
||||
BENAZEPRIL HYDROCHLORIDE, MAGNESIUM, ERGOCALCIFEROL, CINNAMON, HYDROXYZINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NIACINAMIDE, |
||||
| 95 | 26934511 |
76 | ||
Rheumatoid arthritis, Hand deformity, Grip strength decreased, Blood pressure increased, Hypoacusis, Cough, Product blister packaging issue, |
||||
BENAZEPRIL HYDROCHLORIDE, VALSARTAN AND HYDROCHLOROTHIAZIDE, VALSARTAN AND HYDROCHLOROTHIAZIDE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 96 | 26934523 |
51 | ||
Blood pressure increased, Drug ineffective, Product complaint, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CITALOPRAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 97 | 26934531 |
63 | ||
Blood pressure increased, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, AMLODIPINE, VALSARTAN, VALSARTAN ORAL, ALISKIREN HEMIFUMARATE, |
||||
| 98 | 26935045 |
US |
57 | 1 |
Multiple sclerosis, Injection site pain, Product communication issue, Blood pressure increased, |
||||
EVOLOCUMAB, |
||||
| 99 | 26935457 |
US |
2 | |
Impaired driving ability, Blood pressure increased, Sedation, Balance disorder, Feeling abnormal, Somnolence, Dizziness, |
||||
LORAZEPAM, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 100 | 26935932 |
75 | ||
Blood pressure increased, |
||||
OPICAPONE, LEVODOPA, SELEGILINE HYDROCHLORIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30